Olagunju Peter 4
4 · TCR2 THERAPEUTICS INC. · Filed Dec 5, 2022
Insider Transaction Report
Form 4
Olagunju Peter
Chief Technical Officer
Transactions
- Sale
Common Stock
2022-12-02$1.39/sh−1,273$1,766→ 34,328 total - Exercise/Conversion
Common Stock
2022-12-01+33,409→ 35,601 total - Exercise/Conversion
Restricted Stock Unit
2022-12-01+33,409→ 62,047 total→ Common Stock (33,409 underlying)
Holdings
- 2,192
Common Stock
Footnotes (4)
- [F1]Represents the the aggregate number of common stock converted from restricted stock units granted to the reporting person on 11/17/2022 pursuant to the issuer's offer to exchange eligible options for new restricted stock units program.
- [F2]Each restricted stock unit represents a right to receive one share of the issuer's common stock at the time of vesting for no consideration.
- [F3]The sales reported represent the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of restricted stock units. These sales were automatic and intended to qualify under Rule 10b5-1.
- [F4]35% of these restricted stock units vested on December 1, 2022, 25% will vest on each of December 1, 2023 and December 1, 2024, and the remaining 15% will vest on December 1, 2025.